• Harbour Biomed gives Hong Kong new IPO dose

    China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing.

    • 05:00 AM
  • JD Health to close HK$27bn IPO book early

    JD Health International is set to close the international investor book for its up-to HK$27bn ($3.5bn) IPO a day early, according to a source familiar with matter.

    • 27 Nov 2020
  • Evergrande Property Services prices HK IPO low at $1.8bn

    Evergrande Property Services Group, the property management arm of one China’s most debt-laden developers, wrapped up its IPO toward the bottom of price guidance after relying largely on Chinese investors.

    • 27 Nov 2020
  • Datang kicks off $198m Hong Kong listing

    Chinese property developer Datang Group Holdings has set its IPO in motion, opening the book for an offer that could fetch up to HK$1.5bn ($197.9m).

    • 27 Nov 2020
  • JD Health IPO has “phenomenal” first day of bookbuilding

    JD Health International launched 2020’s largest healthcare listing this week, hitting the road to raise up to HK$27bn ($3.5bn) in a Hong Kong IPO. The issuer blends healthcare and technology, two of the hottest sectors in the IPO market this year. It covered the deal multiple times on the first day. Jonathan Breen reports.

    • 26 Nov 2020
  • China Resources Mixc, Leading launch HK IPOs

    China Resources Mixc Lifestyle Services, the property management business of state-owned developer China Resources Land, kicked off bookbuilding for its Hong Kong listing this week, followed quickly by mainland-based developer Leading Holding Group.

    • 26 Nov 2020
  • Evergrande property manager finds big demand for IPO

    Evergrande Property Services Group, the property management arm of embattled developer Evergrande Group, was wrapping up its Hong Kong IPO on a strong note as GlobalCapital Asia went press, with proceeds of up to HK$15.8bn ($2bn) looking within reach.

    • 26 Nov 2020
  • JD Health starts roadshow for $3.5bn IPO

    JD Health International has hit the road with an up-to HK$27bn ($3.5bn) Hong Kong IPO, set to be the largest primary listing in the city this year.

    • 25 Nov 2020
  • Evergrande Property Services launches HK$16bn IPO

    China's Evergrande Property Services Group has kicked off its IPO, aiming to raise up to HK$15.8bn ($2bn) with strong support from friends-and-family investors.

    • 23 Nov 2020
  • Central China pushes out $300m bond

    Central China Real Estate paid up for its $300m return to the bond market on Tuesday, navigating weaker investor sentiment to get its deal over the finish line.

    • 18 Nov 2020
  • Jingrui nets $240m from LM outing

    High yield property company Jingrui Holdings raised $240m on Monday as part of an exchange and new money exercise.

    • 17 Nov 2020
  • Hong Kong IPOs: Four companies pre-market listings

    JD Health International, Evergrande Property Services Group, detergent maker Blue Moon Group Holdings and video marketing company Netjoy Holdings have started pre-marketing their Hong Kong IPOs.

    • 16 Nov 2020
  • India’s Gland Pharma scores record listing

    Gland Pharma has completed India’s largest pharmaceutical IPO, a Rp65bn ($870.6m) deal that sailed through on demand from institutional accounts. But the issuer’s Chinese ties and a wobble in pharma stocks blunted retail investor interest. Jonathan Breen reports.

    • 12 Nov 2020
  • Jinke Smart Services prices HK$5.9bn IPO at mid-point

    Jinke Smart Services Group, a Chinese property manager, raised HK$5.94bn ($766.1m) this week after sealing its IPO at the mid-point of the marketed range.

    • 12 Nov 2020
  • Chinese borrowers rush to bond market

    A flurry of Chinese corporations rushed to the dollar bond market on Wednesday, raising a total of $1.19bn between them.

    • 12 Nov 2020
  • Redco uses up bond quota to meet refi needs

    Redco Properties Group has tackled some of its upcoming maturities by selling a new $266m bond to refinance debt.

    • 11 Nov 2020
  • China property companies keep up bond momentum

    Three Chinese property companies launched dollar bonds on Monday, continuing to take advantage of the post-US election momentum.

    • 10 Nov 2020
  • Fosun-backed Gland Pharma launches $876m Indian IPO

    Gland Pharma, a subsidiary of Chinese conglomerate Shanghai Fosun Pharmaceutical Group, has started bookbuilding for its Indian IPO, set to be the largest pharmaceutical listing in the country.

    • 10 Nov 2020
  • Bond market bounces back after US elections

    Three property companies from Greater China hit the bond market last Friday, raising $850m between them even as the US presidential election battle raged on. With Joe Biden now announced as the president-elect, the issuance spree in Asia only picked up pace on Monday.

    • 09 Nov 2020
  • Jinke hits the road with $816m Hong Kong IPO

    Chinese property manager Jinke Smart Services Group has launched its IPO. It is aiming to pocket up to HK$6.3bn ($815.9m) from the deal.

    • 05 Nov 2020
  • Fosun-backed Gland Pharma readies Rp65bn IPO

    Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.

    • 04 Nov 2020
  • RemeGen nets $515m from Hong Kong IPO

    Chinese biopharmaceutical firm RemeGen has raised HK$3.99bn ($514.7m) after pricing its IPO at the top of the marketed range, according to a source familiar with the matter.

    • 04 Nov 2020
  • Sunkwan Properties targets HK$1.3bn listing

    Chinese developer Sunkwan Properties has kicked off its IPO roadshow. It is aiming to raise up to HK$1.25bn ($161.2m).

    • 02 Nov 2020

Panda Bonds Top Arrangers

Rank Arranger Share % by Volume
1 Bank of China (BOC) 18.45
2 Industrial and Commercial Bank of China (ICBC) 13.56
3 China Merchants Bank Co 12.10
4 China Construction Bank (CCB) 9.85
5 Agricultural Bank of China (ABC) 8.93

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 Morgan Stanley 22.44 89 7.39%
2 CITIC Securities 19.78 121 6.52%
3 China International Capital Corp Ltd 19.76 95 6.51%
4 Goldman Sachs 17.76 107 5.85%
5 China Securities Co Ltd 15.52 60 5.11%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 HSBC 28.85 223 7.62%
2 Citi 28.41 169 7.50%
3 JPMorgan 19.37 134 5.12%
4 BofA Securities 18.70 103 4.94%
5 Standard Chartered Bank 17.89 163 4.72%

Asian polls & awards